Comparisons between Criteria for Successful Radioiodine Remnant Ablation in a cohort of Patients with Papillary Thyroid Carcinoma

Author:

Wang Junyao1,Chai Hong1,Yang Jiahuan1,Zhu Yunyun1,Zhong Peng1,Chen Zequan1,He Ziyan1,Zhang Ke1,Chen Libo1

Affiliation:

1. Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Abstract

Abstract

Objective Multiple criteria for successful radioiodine remnant ablation (RRA) under thyroid-stimulating hormone (TSH)-stimulation have been inconsistently employed, resulting in difficulties in efficacy comparison and iatrogenic hypothyroidism. Establishing an optimal standard for successful RRA is a priority. Methods Five existing criteria for successful RRA under endogenous TSH-stimulation were retrieved and then compared in a cohort of 51 patients with papillary thyroid cancer post RRA. Criterion A, a negative diagnostic 131I whole-body scan (DxWBS); Criterion B, a negative DxWBS and serum thyroglobulin (Tg) < 2 ng/mL, irrespective of anti-thyroglobulin antibody (TgAb) level; Criterion C, Tg < 2 ng/mL with TgAb ≤ 46 IU/mL; Criterion D, a negative DxWBS and Tg < 1ng/mL with TgAb ≤ 100 IU/mL or a negative DxWBS with TgAb > 100 IU/mL; Criterion E, a negative DxWBS and Tg ≤ 1 ng/mL with TgAb ≤ 46 IU/mL. Non-TSH-stimulated DxWBS was compared to TSH-stimulated DxWBS. Results Success rates of 98.0% (50/51), 78.4% (40/51), 78.0% (32/41), 64.7% (33/51) and 56.1% (23/41) were achieved regarding the criteria A, B, C, D, and E, respectively. The success rate of RRA by criterion A was significantly higher than those by other criteria. The similar success rates of RRA by criteria B and C were higher than that by criterion E. The success rate of RRA regarding non-TSH stimulated DxWBS was comparable to that of TSH-stimulated DxWBS, with a negative predictive value of 98.0%. Conclusions Compared with negative TSH-stimulated DxWBS criterion, the success rate of RRA decreases when the cut-off value of serum Tg is introduced. A negative non-TSH-stimulated DxWBS seems promising in predicting a successful RRA.

Publisher

Springer Science and Business Media LLC

Reference29 articles.

1. Boucai L, Zafereo M, Cabanillas ME. Thyroid Cancer: A Review. Jama. 2024;331(5):425–35.

2. Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients as an Indication for Radioiodine Adjuvant Therapy: A Prospective Multicenter Study;Cheng L;J Nucl Med,2021

3. Optimizing the indication of initial radioiodine oncolytic treatment for metastatic differentiated thyroid cancer by diagnostic (131)I scan;He Z;Clin Radiol,2024

4. Thyroid cancer;Chen DW;Lancet,2023

5. Different Radioiodine Dose for Remnant Thyroid Ablation in Patients With Differentiated Thyroid Cancer: A Meta-analysis;Song X;Clinical nuclear medicine,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3